Loading...
Loading...
Below are the top NASDAQ stocks in the healthcare sector in terms of return on assets.
The trailing-twelve-month return on assets at
Enzon Pharmaceuticals IncENZN is 88.70 percent. Enzon Pharmaceuticals' revenue for the same period is $27.50 million.
The trailing-twelve-month return on assets at
NewLink Genetics CorpNLNK is 73.90 percent. NewLink Genetics' revenue for the same period is $211.50 million.
The trailing-twelve-month return on assets at
Affimed NV AFMD is 60.10 percent. Affimed's revenue for the same period is $5.80 million.
The trailing-twelve-month return on assets at
Enanta Pharmaceuticals Inc ENTA is 59.70 percent. Enanta Pharmaceuticals' revenue for the same period is $179.60 million.
The trailing-twelve-month return on assets at
ABIOMED, Inc. ABMD is 45.40 percent. ABIOMED's revenue for the same period is $230.30 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: Trading IdeasHealthcare Sector
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in